Acute Coronary Syndromes

Chapter

Abstract

Coronary syndromes that cause a relatively rapid onset or increase of symptoms or ischemia are termed acute coronary syndromes (ACSs). ACS is a continuum of unstable coronary syndromes that stretches from “unstable angina” to acute ST-segment myocardial infarction (STEMI). In this chapter, we will discuss the portion of the spectrum that extends from unstable angina to minor non-ST-segment myocardial infarction (NSTEMI). STEMI and related syndromes are discussed in Chap. 18.

The hallmark of ACSs is a fairly abrupt onset of angina (or equivalent ischemic symptoms, such as dyspnea and diaphoresis) or rapid worsening of preexisting ischemic cardiac symptoms. For more than a century, this change in clinical symptoms has been associated with a high risk of subsequent myocardial infarction or cardiac death (Lancet 1:860, 1972). The syndrome has also been termed crescendo angina, preinfarction angina, and unstable angina, all connoting its ominous natural history.

Keywords

Cholesterol Catheter Ischemia Aspirin Heparin 

References

  1. 1.
    Fulton M, Lutz W, Donald KW, et al. Natural history of unstable angina. Lancet. 1972;1:860.PubMedCrossRefGoogle Scholar
  2. 2.
    Tanaka A, Imanishi T, Kitabata H, et al. Morphology of exertion-triggered plaque rupture in patients with acute coronary syndrome: an optical coherence tomography study. Circulation. 2008;118(23):2368–73.PubMedCrossRefGoogle Scholar
  3. 3.
    Shah PK. Pathophysiology of coronary thrombosis: role of plaque rupture and plaque erosion. Prog Cardiovasc Dis. 2002;44:357–68.PubMedCrossRefGoogle Scholar
  4. 4.
    Davignon J, Ganz P. Role of endothelial dysfunction in atherosclerosis. Circulation. 2004;109(23 Suppl 1):III27–32.PubMedGoogle Scholar
  5. 5.
    Kolodgie FD, Burke AP, Farb A, et al. The thin-cap fibroatheroma: a type of vulnerable plaque: the major precursor lesion to acute coronary syndromes. Curr Opin Cardiol. 2001;16:285–92.PubMedCrossRefGoogle Scholar
  6. 6.
    Takano M, Mizuno K, Okamatsu K, Yokoyama S, Ohba T, Sakai S. Mechanical and structural characteristics of vulnerable plaques: analysis by coronary angioscopy and intravascular ultrasound. J Am Coll Cardiol. 2001;38:99–104.PubMedCrossRefGoogle Scholar
  7. 7.
    Falk E. Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion. Circulation. 1985;71:699–708.PubMedCrossRefGoogle Scholar
  8. 8.
    Fitzgerald DJ, Roy L, Catella F, et al. Platelet activation in unstable coronary disease. N Engl J Med. 1986;315:983–9.PubMedCrossRefGoogle Scholar
  9. 9.
    Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation. 1995;92:657–71.PubMedCrossRefGoogle Scholar
  10. 10.
    Willerson JT, Golino P, Eidt J, et al. Specific platelet mediators and unstable coronary artery lesions. Experimental evidence and potential clinical implications. Circulation. 1989;80:198–205.PubMedCrossRefGoogle Scholar
  11. 11.
    Bertrand ME, LaBlanche JM, Tilmant PY, et al. Frequency of provoked coronary arterial spasm in 1089 consecutive patients undergoing coronary arteriography. Circulation. 1982;65:1299–308.PubMedCrossRefGoogle Scholar
  12. 12.
    Isner JM, Estes III NA, Thompson PD, et al. Acute cardiac events temporally related to cocaine abuse. N Engl J Med. 1986;315:1438–43.PubMedCrossRefGoogle Scholar
  13. 13.
    Cangella F, Medolla A, De Fazio G, et al. Stress-induced cardiomyopathy presenting as acute coronary syndrome: Tako-tsubo in Mercogliano, southern Italy. Cardiovasc Ultrasound. 2007;5:36.PubMedCrossRefGoogle Scholar
  14. 14.
    Braunwald E. Unstable angina: a classification. Circulation. 1989;80:410–4.PubMedCrossRefGoogle Scholar
  15. 15.
    Savonitto S, Ardissino D, Granger CB, et al. Prognostic value of the admission electrocardiogram in acute coronary syndromes. JAMA. 1999;281:707–13.PubMedCrossRefGoogle Scholar
  16. 16.
    Bassand J, Hamm CW, Ardissino D, et al. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Eur Heart J. 2007;13:1598–660.Google Scholar
  17. 17.
    Cannon CP, McCabe CH, Stone PH, et al. The electrocardiogram predicts one-year outcome of patients with unstable angina and non-Q-wave myocardial infarction: results of the TIMI III Registry ECG Ancillary Study. Thrombolysis in myocardial ischemia. J Am Coll Cardiol. 1997;30:133–40.PubMedCrossRefGoogle Scholar
  18. 18.
    Hamm CW, Braunwald E. A classification of unstable angina revisited. Circulation. 2000;102:118–22.PubMedCrossRefGoogle Scholar
  19. 19.
    American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics – 2010 update: a report from the American Heart Association. Circulation. 2010;121:e46–215.CrossRefGoogle Scholar
  20. 20.
    Farb A, Tang AL, Burke AP, Sessums L, Liang Y, Virmani R. Sudden coronary death. Frequency of active coronary lesions, inactive coronary lesions, and myocardial infarction. Circulation. 1995;92:1701–9.PubMedCrossRefGoogle Scholar
  21. 21.
    Antman EM, Cohen M, Bernink PJ, et al. The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making. JAMA. 2000;284:835–42.PubMedCrossRefGoogle Scholar
  22. 22.
    Goldman L, Cook EF, Johnson PA, Brand DA, Rouan GW, Lee TH. Prediction of the need for intensive care in patients who come to the emergency departments with acute chest pain. N Engl J Med. 1996;334:1498–504.PubMedCrossRefGoogle Scholar
  23. 23.
    Eagle KA, Lim MJ, Dabbous OH, et al. GRACE Investigators. A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry. JAMA. 2004;291:2727–33.PubMedCrossRefGoogle Scholar
  24. 24.
    Ottani F, Galvani M, Ferrini D, et al. Prodromal angina limits infarct size. A role for ischemic preconditioning. Circulation. 1995;91:291–7.PubMedCrossRefGoogle Scholar
  25. 25.
    Mladenovic ZT, Angelkov-Ristic A, Tavciovski D, Mijailovic Z, Gligic B, Cosic Z. The cardioprotective role of preinfarction angina as shown in outcomes of patients after first myocardial infarction. Tex Heart Inst J. 2008;35:413–8.PubMedGoogle Scholar
  26. 26.
    Schwartz H, Leiboff RH, Bren GB, et al. Temporal evolution of the human coronary collateral circulation after myocardial infarction. J Am Coll Cardiol. 1984;4:1088–93.PubMedCrossRefGoogle Scholar
  27. 27.
    Liu GS, Thornton J, Van Winkle DM, Stanley AW, Olsson RA, Downey JM. Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptors in rabbit heart. Circulation. 1991;84:350–6.PubMedCrossRefGoogle Scholar
  28. 28.
    McMahon MM, Brown BG, Cukingnan R, et al. Quantitative coronary angiography: measurement of the “critical” stenosis in patients with unstable angina and single-vessel disease without collaterals. Circulation. 1979;60(1):106–13.PubMedCrossRefGoogle Scholar
  29. 29.
    Levin DC, Fallon JT. Significance of the angiographic morphology of localized coronary stenoses: histopathologic correlations. Circulation. 1982;66:316–20.PubMedCrossRefGoogle Scholar
  30. 30.
    Ambrose JA, Tannenbaum MA, Alexopoulos D, et al. Angiographic progression of coronary artery disease and the development of myocardial infarction. J Am Coll Cardiol. 1988;12:56–62.PubMedCrossRefGoogle Scholar
  31. 31.
    Wilson RF, Holida MD, White CW. Quantitative angiographic morphology of coronary stenoses leading to myocardial infarction or unstable angina. Circulation. 1986;73:286–93.PubMedCrossRefGoogle Scholar
  32. 32.
    Hamdan A, Assali A, Fuchs S, Battler A, Kornowski R. Imaging of vulnerable coronary artery plaques. Catheter Cardiovasc Interv. 2007;70:65–74.PubMedCrossRefGoogle Scholar
  33. 33.
    Rodriguez-Granillo GA, Garcia-Garcia HM, Mc Fadden EP, et al. In vivo intravascular ultrasound-derived thin-cap fibroatheroma detection using ultrasound radiofrequency data analysis. J Am Coll Cardiol. 2005;46:2038–42.PubMedCrossRefGoogle Scholar
  34. 34.
    Jang IK, Tearney GJ, MacNeil B, et al. In vivo characterization of coronary atherosclerotic plaque by use of optical coherence tomography. Circulation. 2005;111:1551–5.PubMedCrossRefGoogle Scholar
  35. 35.
    Mizukoshi M, Imanishi T, Tanaka A, et al. Clinical classification and plaque morphology determined by optical coherence tomography in unstable angina pectoris. Am J Cardiol. 2010;106:323–8.PubMedCrossRefGoogle Scholar
  36. 36.
    Stefanadis C, Diamantopoulos L, Vlachopoulos C, et al. Thermal heterogeneity within human atherosclerotic coronary arteries detected in vivo: a new method of detection by application of a special thermography catheter. Circulation. 1999;99:1965–71.PubMedCrossRefGoogle Scholar
  37. 37.
    Caplan JD, Waxman S, Nesto RW, Muller JE. Near-infrared spectroscopy for the detection of vulnerable coronary artery plaques. J Am Coll Cardiol. 2006;47:C92–6.PubMedCrossRefGoogle Scholar
  38. 38.
    Manini AF, Dannemann N, Brown DF, et al. Rule Out Myocardial Infarction using Coronary Artery Tomography (ROMICAT) study investigators. Limitations of risk score models in patients with acute chest pain. Am J Emerg Med. 2009;27:43–8.PubMedCrossRefGoogle Scholar
  39. 39.
    Henneman MM, Schuijf JD, Pudziute G, et al. Noninvasive evaluation with multislice computed tomography in suspected acute coronary syndrome: plaque morphology on multislice computed tomography versus coronary calcium score. J Am Coll Cardiol. 2008;52:216–22.PubMedCrossRefGoogle Scholar
  40. 40.
    Telford AM, Wilson C. Trial of heparin versus atenolol in prevention of myocardial infarction in intermediate coronary syndrome. Lancet. 1981;1:1225–8.PubMedCrossRefGoogle Scholar
  41. 41.
    Theroux P, Ouimet H, McCans J, et al. Aspirin, heparin, or both to treat acute unstable angina. N Engl J Med. 1988;319:1105–11.PubMedCrossRefGoogle Scholar
  42. 42.
    Ferguson JJ, Califf RM, Antman EM, et al. SYNERGY Trial Investigators: enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial. JAMA. 2004;292(1):45–54.PubMedCrossRefGoogle Scholar
  43. 43.
    Peters RJ, Mehta SR, Fox KA, et al. Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes: observations from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study. Circulation. 2003;108:1682–7.PubMedCrossRefGoogle Scholar
  44. 44.
    Simoons ML. GUSTO IV-ACS Investigators: effect of glycoprotein IIb/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation: the GUSTO IV-ACS randomised trial. Lancet. 2001;357(9272):1915–24.PubMedCrossRefGoogle Scholar
  45. 45.
    Yusuf S, Wittes J, Friedman L. Overview of results of randomized clinical trials in heart disease. II. Unstable angina, heart failure, primary prevention with aspirin, and risk factor modification. JAMA. 1988;260:2259–63.PubMedCrossRefGoogle Scholar
  46. 46.
    Curfman GD, Heinsimer JA, Lozner EC, Fung HL. Intravenous nitroglycerin in the treatment of spontaneous angina pectoris: a prospective, randomized trial. Circulation. 1983;67:276–82.PubMedCrossRefGoogle Scholar
  47. 47.
    Murphy SA, Cannon CP, Wiviott SD, et al. Effect of intensive lipid-lowering therapy on mortality after acute coronary syndrome (a patient-level analysis of the Aggrastat to Zocor and Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 trials). Am J Cardiol. 2007;100:1047–51.PubMedCrossRefGoogle Scholar
  48. 48.
    de Winter RJ, Windhausen F, Cornel JH, et al. Early invasive versus selectively invasive management for acute coronary syndromes. N Engl J Med. 2005;353:1095–104.PubMedCrossRefGoogle Scholar
  49. 49.
    Lagerqvist B, Husted S, Kontny F, et al. A long-term perspective on the protective effects of an early invasive strategy in unstable coronary artery disease: two-year follow-up of the FRISC-II invasive study. J Am Coll Cardiol. 2002;40:1902–14.PubMedCrossRefGoogle Scholar
  50. 50.
    Mehta SR, Cannon CP, Fox KA, et al. Routine vs. selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trials. JAMA. 2005;293:2908–17.PubMedCrossRefGoogle Scholar
  51. 51.
    Montalescot G, Cayla G, Collet JP, et al. Intervention timing and acute coronary syndromes. JAMA. 2010;303:131–2.CrossRefGoogle Scholar
  52. 52.
    Mauri L, Rogers C, Baim DS. Devices for distal protection during percutaneous coronary revascularization. Circulation. 2006;113:2651–6.PubMedCrossRefGoogle Scholar
  53. 53.
    Eagle KA, Lim MJ, Dabbous OH, et al. GRACE Investigators. A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry. JAMA. 2004;291:2727–33.PubMedCrossRefGoogle Scholar
  54. 54.
    McCormick JR, Schick Jr EC, McCabe CH, Kronmal RA, Ryan TJ. Determinants of operative mortality and long-term survival in patients with unstable angina – the CASS experience. J Thorac Cardiovasc Surg. 1985;89:683–8.PubMedGoogle Scholar
  55. 55.
    Tu JV, Sykora K, Naylor CD. Assessing the outcomes of coronary artery bypass graft surgery: how many risk factors are enough? J Am Coll Cardiol. 1997;30:1317–23.PubMedCrossRefGoogle Scholar
  56. 56.
    Rahimtoola SH, Nunley D, Grunkemeier G, Tepley J, Lambert L, Starr A. Ten-year survival after coronary bypass surgery for unstable angina. N Engl J Med. 1983;308:676–81.PubMedCrossRefGoogle Scholar
  57. 57.
    Boden WE, O’Rourke RA, Crawford MH, et al. Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy. Veterans Affairs Non-Q-Wave Infarction Strategies in Hospital (VANQWISH) Trial Investigators. N Engl J Med. 1998;338:1785–92.PubMedCrossRefGoogle Scholar
  58. 58.
    Neumann FJ, Kastrati A, Pogatsa-Murray G, et al. Evaluation of prolonged antithrombotic pretreatment (“cooling-off” strategy) before intervention in patients with unstable coronary syndromes: a randomized controlled trial. JAMA. 2003;290:1593–9.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  1. 1.Division of Cardiovascular MedicineUniversity of MinnesotaMinneapolisUSA

Personalised recommendations